135 related articles for article (PubMed ID: 9188900)
21. A prospective study of the financial costs of multiple sclerosis at different stages of the disease.
Orlewska E; Mierzejewski P; Zaborski J; Kruszewska J; Wicha W; Fryze W; Drozdowski W; Skibicka I; Mirowska-Guzel D; Czlonkowski A; Czlonkowska A
Eur J Neurol; 2005 Jan; 12(1):31-9. PubMed ID: 15613144
[TBL] [Abstract][Full Text] [Related]
22. [The costs of a multiple sclerosis relapse in Catalonia (Spain)].
Casado V; Martinez-Yelamos S; Martinez-Yelamos A; Carmona O; Alonso L; Romero L; Moral E; Arbizu T
Neurologia; 2006 Sep; 21(7):341-7. PubMed ID: 16977554
[TBL] [Abstract][Full Text] [Related]
23. Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age.
Gyllensten H; Wiberg M; Alexanderson K; Norlund A; Friberg E; Hillert J; Ernstsson O; Tinghög P
Eur J Health Econ; 2018 Apr; 19(3):435-446. PubMed ID: 28488184
[TBL] [Abstract][Full Text] [Related]
24. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
25. Cost of multiple sclerosis in the Czech Republic: the COMS study.
Blahova Dusankova J; Kalincik T; Dolezal T; Kobelt G; Havrdova E
Mult Scler; 2012 May; 18(5):662-8. PubMed ID: 21965424
[TBL] [Abstract][Full Text] [Related]
26. Contribution of intangible costs to the economic burden of multiple sclerosis.
Wundes A; Brown T; Bienen EJ; Coleman CI
J Med Econ; 2010; 13(4):626-32. PubMed ID: 20950249
[TBL] [Abstract][Full Text] [Related]
27. The cost of vision loss in Canada. 2. Results.
Cruess AF; Gordon KD; Bellan L; Mitchell S; Pezzullo ML
Can J Ophthalmol; 2011 Aug; 46(4):315-8. PubMed ID: 21816249
[TBL] [Abstract][Full Text] [Related]
28. The cost of multiple sclerosis in Australia.
Taylor B; McDonald E; Fantino B; Sedal L; MacDonnell R; Pittas F; Groom T; Beresniak A
J Clin Neurosci; 2007 Jun; 14(6):532-9. PubMed ID: 17430777
[TBL] [Abstract][Full Text] [Related]
29. Direct and indirect economic consequences of multiple sclerosis in Ireland.
Fogarty E; Walsh C; McGuigan C; Tubridy N; Barry M
Appl Health Econ Health Policy; 2014 Dec; 12(6):635-45. PubMed ID: 25227118
[TBL] [Abstract][Full Text] [Related]
30. Costs of multiple sclerosis - extrapolation of Czech data to Polish patients.
Szmurło D; Fundament T; Ziobro M; Kruntorádová K; Doležal T; Głogowski C
Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):451-8. PubMed ID: 24702130
[TBL] [Abstract][Full Text] [Related]
31. Economic burden in a German cohort of patients with multiple sclerosis.
Reese JP; John A; Wienemann G; Wellek A; Sommer N; Tackenberg B; Balzer-Geldsetzer M; Dodel R
Eur Neurol; 2011; 66(6):311-21. PubMed ID: 22086151
[TBL] [Abstract][Full Text] [Related]
32. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
Rotstein Z; Hazan R; Barak Y; Achiron A
Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884
[TBL] [Abstract][Full Text] [Related]
33. Net economic costs of dementia in Canada.
Ostbye T; Crosse E
CMAJ; 1994 Nov; 151(10):1457-64. PubMed ID: 7954140
[TBL] [Abstract][Full Text] [Related]
34. How much is the cost of multiple sclerosis--systematic literature review.
Kolasa K
Przegl Epidemiol; 2013; 67(1):75-9, 157-60. PubMed ID: 23745380
[TBL] [Abstract][Full Text] [Related]
35. Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US.
Jones E; Pike J; Marshall T; Ye X
BMC Health Serv Res; 2016 Jul; 16():294. PubMed ID: 27443278
[TBL] [Abstract][Full Text] [Related]
36. The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
Adelman G; Rane SG; Villa KF
J Med Econ; 2013; 16(5):639-47. PubMed ID: 23425293
[TBL] [Abstract][Full Text] [Related]
37. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
38. Impact on healthcare resource utilization of multiple sclerosis in Spain.
Sicras-Mainar A; Ruíz-Beato E; Navarro-Artieda R; Maurino J
BMC Health Serv Res; 2017 Dec; 17(1):854. PubMed ID: 29284493
[TBL] [Abstract][Full Text] [Related]
39. Economic burden of multiple sclerosis in a population with low physical disability.
García-Domínguez JM; Maurino J; Martínez-Ginés ML; Carmona O; Caminero AB; Medrano N; Ruíz-Beato E;
BMC Public Health; 2019 May; 19(1):609. PubMed ID: 31109317
[TBL] [Abstract][Full Text] [Related]
40. The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study.
Jennum P; Frederiksen JL; Wanscher B; Kjellberg J
Acta Neurol Scand; 2013 Apr; 127(4):242-50. PubMed ID: 22812660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
